Using the PIVO device to collect blood cultures in the emergency department

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective implementation study that will train ED staff to use the needle-free PIVO device for blood culture collection at three Intermountain Health emergency departments, with potential expansion to three additional sites. Training will occur in October 2025 and cover indications, technique, workflow integration, and Epic documentation, followed by 13 months of protocol implementation and data collection from November 2025 to October 2026. The team will monitor PIVO utilization, blood culture contamination rates, and adoption metrics to compare performance with existing collection methods. Results will determine whether the protocol should be expanded to the planned secondary sites.

Why it matters

Who can join: the full rules

Inclusion Criteria: Patients in whom blood cultures are obtained in the emergency department.

\-

Exclusion Criteria: none

\-

Where it's running

• Park City Hospital
  Park City, Utah, United States Recruiting

Study contacts

• Study coordinator: Troy E. Madsen, MD
• Email: troy.madsen@imail.org
• Phone: 435-658-7500

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Personalized IV fluid care for sepsis in the emergency department

  This study will test whether giving IV fluids based on each adult's heart response helps people with suspected sepsis in the emergency department recover more safely than standard fluid care.

  Recruiting University Medical Center Groningen · Groningen, Provincie Groningen · NCT07009665

• Ruta C and Vitamin C in Sepsis: Adding antioxidants to standard care

  This trial tests whether adding Ruta C (rutin plus vitamin C) or vitamin C alone to standard sepsis treatment helps adults in the ICU stay shorter and recover better.

  Recruiting Ain Shams University · Cairo, Cairo Governorate · NCT07922213

• Early detection of sepsis-related blood clotting problems in severe burn patients

  This study tests how well the JAAM-2 score can detect sepsis-induced coagulopathy early in adults with severe burns who develop sepsis in the ICU.

  Recruiting Center for Traumatology and Major Burns, Ben Arous · Tunis · NCT07914205

• Neutrophil EMR3 as a biomarker for sepsis in ICU patients

  Researchers will test whether measuring EMR3 on neutrophils helps diagnose sepsis, monitor progression, and predict outcomes in adults in Chinese ICUs.

  Recruiting Sir Run Run Shaw Hospital · Hangzhou, Zhejiang · NCT07896018

• Thymalfasin added to standard care for adults with sepsis and immune dysfunction

  This study tests whether thymosin alpha-1 helps restore immune function in adults with sepsis who have weakened immunity.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07866118

• Multicenter group study of sepsis and ARDS in China

  This study tests how sepsis and ARDS differ among adults across several Chinese hospitals and builds a biobank to understand why some patients do better or worse.

  Recruiting at 24 sites Shanghai Zhongshan Hospital · Xiamen, Fujian and 23 other locations · NCT07863908

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.